Ladapo O. Shyngle, M.D.; Denial of Application, 6056-6059 [E9-2331]
Download as PDF
6056
Federal Register / Vol. 74, No. 22 / Wednesday, February 4, 2009 / Notices
Rules of Practice and Procedure (19 CFR
210.42).
Issued: January 29, 2009.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E9–2293 Filed 2–3–09; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Supplemental Notice of Lodging of
Consent Decree Under the
Comprehensive Environmental
Response, Compensation, and Liability
Act (CERCLA)
On January 15, 2009, the Department
of Justice published notice of lodging of
a proposed Consent Decree on January
9, 2009, with the United States District
Court for the District of Kansas in
United States v. Citibank Global Market
Holdings, Inc., Civil Action No. 09–CV–
4002–SAC, under the Comprehensive
Environmental Response,
Compensation, and Liability Act
(‘‘CERCLA’’), 42 U.S.C. 9601–9675. See
74 FR 2617 (Jan. 15, 2009).
The Department of Justice hereby
supplements its Notice to indicate that
Citibank Global Market Holdings, Inc.,
is now known as Citigroup Global
Market Holdings, Inc. Accordingly, the
settlement parties are the United States,
Citigroup Global Market Holdings, Inc.,
and the U.S. Steel Corporation. This
opportunity to comment on the
proposed consent decree is extended for
30 days from the date of publication of
this Supplemental Notice.
Robert E. Maher, Jr.,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. E9–2272 Filed 2–3–09; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Ladapo O. Shyngle, M.D.; Denial of
Application
On April 15, 2008, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Ladapo O. Shyngle, M.D.
(Respondent), of Tampa, Florida. The
Show Cause Order proposed the denial
of Respondent’s pending application for
a DEA Certificate of Registration as a
practitioner, on the ground that his
registration ‘‘would be inconsistent with
VerDate Nov<24>2008
14:33 Feb 03, 2009
Jkt 217001
the public interest.’’ Show Cause Order
at 1.
More specifically, the Show Cause
Order alleged that Respondent had
issued controlled-substance
prescriptions to customers of an internet
site who were located throughout the
United States based on a questionnaire
and/or telephone consultation, and that
these prescriptions lacked ‘‘a legitimate
medical purpose’’ and were issued
‘‘outside the usual course of
professional practice, in violation of 21
CFR 1306.04(a) and 21 U.S.C.
841(a)(1).’’ Id. The Order further alleged
that notwithstanding that his Florida
medical license had expired on August
24, 2002, Respondent continued to issue
prescriptions for controlled substances.
Id. Relatedly, the Order alleged that
Respondent had violated other state
laws prohibiting the unauthorized
practice of medicine by issuing
prescriptions for controlled substances
to residents of States where he was not
licensed to practice. Id. at 1–2.
On or about April 19, 2008, the Show
Cause Order was served on Respondent
by delivery to his residence. On May 14,
2008, Respondent requested a hearing
on the allegations and the matter was
placed on the docket of the Agency’s
Administrative Law Judges (ALJ).
On the same date, Respondent also
sought to withdraw his application,
explaining that the State of Florida had
criminally charged him with engaging
in the unlicensed practice of medicine,
that he intended ‘‘to vigorously defend’’
against this charge, and that in light of
the pending proceeding, it was
premature for the Agency to consider
his application. On May 29, 2008, the
Deputy Assistant Administrator denied
Respondent’s request, reasoning that
‘‘the facts supporting the Order to Show
Cause will not be affected by the
outcome of the state prosecution’’ and
that Respondent ‘‘intend[ed] to continue
professional medical practice and * * *
reapply for a * * * [r]egistration at the
conclusion of the state criminal case.’’
Letter from Joseph T. Rannazzisi to
Respondent’s Counsel (May 29, 2008).
Thereafter, on July 9, 2008,
Respondent withdrew his request for a
hearing. The next day, the ALJ issued an
order terminating the proceeding.
Based on Respondent’s letter
withdrawing his request for a hearing, I
conclude that Respondent has waived
his right to a hearing. I therefore enter
this Final Order without a hearing based
on relevant material contained in the
investigate file, see 21 CFR 1301.43, and
make the following findings.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Findings
On October 3, 2005, Respondent
applied for a DEA Certificate of
Registration as a practitioner which
would authorize him to dispense
controlled substances in schedules II
through V, at the proposed location of
1493 Tampa Park Plaza, Tampa, Florida.
Respondent previously held a
practitioner’s registration which was
issued on December 11, 2000, and
which expired on February 29, 2004.
On August 24, 2000, the Florida
Department of Health issued a ‘‘medical
doctor restricted’’ license to
Respondent. The license expired,
however, on August 24, 2002.
Respondent did not obtain another
medical license until September 16,
2005, when the Florida Department of
Health issued him a ‘‘medical doctor’’
license. This license remains in effect
until January 31, 2010. I further find
that Respondent was not licensed in any
other State when he committed the acts
at issue here.
In 2002, Respondent was hired by
Kenneth Shobola, the owner of a
Tampa, Florida medical clinic (the
Kenaday Medical Clinic), to perform
consultations on persons who were
seeking prescriptions for controlled
substances through Shobola’s Web sites.
While Respondent saw some walk-in
patients at the clinic, in an interview
with DEA Investigators, he admitted
that he saw only about five percent of
the persons he prescribed to, and that
his contact with most of the patients
was limited to a telephone consultation
which lasted five to ten minutes.
Based on the consultations,
Respondent would then typically issue
a prescription for a schedule III
controlled substance containing
hydrocodone; Respondent also issued
prescriptions for diazepam (Valium), a
schedule IV controlled substance, 21
CFR 1308.14(c), and some noncontrolled drugs. While the
prescriptions were initially filled at F &
B Pharmacy (another Tampa-based
pharmacy which was operated by Olu
Oyekoya), F & B eventually pulled out
of the arrangement and all of the
prescriptions were then filled by Ken
Drugs, a pharmacy owned by Shobola.
Respondent would perform up to
twenty consultations a day for Shobola’s
clinic. According to computer records
obtained by Investigators, Respondent
issued over 3800 prescriptions which
were filled by Shobola’s pharmacy.
Approximately seventy-five percent of
the prescriptions were for hydrocodone,
and between the original prescriptions
and refills, Respondent authorized the
dispensing of more than 500,000 dosage
E:\FR\FM\04FEN1.SGM
04FEN1
Federal Register / Vol. 74, No. 22 / Wednesday, February 4, 2009 / Notices
units of the drug. Moreover, the
prescriptions were issued to persons in
forty-one different States.
When asked by Investigators how he
had established a doctor-patient
relationship with the patients he did not
see, Respondent maintained that he did
so because he ‘‘actually spoke to the
patient on the phone,’’ and that the Web
site which arranged the consultations
had the patient’s medical records and
‘‘the driver’s license to identify the
patient.’’ Respondent admitted,
however, that because of the number of
‘‘consults,’’ ‘‘seventy percent’’ of the
time he did not see a patient’s medical
records until after he had issued the
prescription. Respondent also admitted
that there were occasions when he never
saw a patient’s medical records.
Respondent even admitted that ‘‘we did
do refills for patients’’ who had not
submitted records because ‘‘the patient
[was] already in the system, [and] we
already kn[ew] about this patient.’’ 1
Respondent further stated that he was
‘‘not sure whether the law actually gives
specific guidelines as to what
constitutes the patient/physician
relationship because * * * when the
laws were drawn there was no internet.’’
When asked whether he was saying that
he did not know if his prescribing was
legal because he did not know the law,
Respondent replied: ‘‘No, what I’m
saying is * * * I think the law the way
it stands * * * makes a loophole
available in terms of * * * what
constitutes [the] patient/doctor
relationship, when you * * * talk to the
patient on the phone. * * * [T]hat is a
leeway that’s provided and that’s what
I had in mind when I got involved with
* * * the whole thing.’’
Respondent acknowledged, however,
that this method of prescribing
‘‘certainly’’ opened the door to drug
abuse and that ‘‘providing medication
through the internet has to provide
safeguards to make sure that the patients
are genuine, [that] they’re not getting
multiple drugs from different doctors
and that * * * they actually have the
problem that they’re taking about.’’
Moreover, Respondent stated to
Investigators that ‘‘the way we practiced
1 Respondent also acknowledged that a patient
had to have a physical exam at some point and
maintained that the clinic had hired either nurses
or paramedics to perform physical exams on
patients. Even if true, this does not aid Respondent
for two reasons: (1) Respondent has not established
the circumstances in which it may be lawful under
the laws of the various States for a physician to rely
on a physical examination performed by a nurse or
paramedic, and (2) Respondent acknowledged that
seventy percent of the time he did not see the
records until after he prescribed. Respondent thus
routinely prescribed without any independent
assessment and verification of his patients’ medical
complaints.
VerDate Nov<24>2008
14:33 Feb 03, 2009
Jkt 217001
* * * in Kennedy there’s no way you
could get all of those [illegitimate
patients] out of the system * * * 100%
of the time.’’ Respondent further
asserted that ‘‘there was a good
proportion of people that actually
needed help that got the help,’’ but
acknowledged that ‘‘there were quite a
few that [were] just doctor hopping or
* * * shopping for medication.’’
As examples of Respondent’s
prescribing, the Government submitted
copies of fourteen prescriptions which
Respondent issued for such drugs as
Norco (10/325 mg.), Lortab (10/500 mg.),
Vicoprofen (7.5/200 mg.), and Vicodin
(7.5/750 mg.), all of which are schedule
III controlled substances containing
hydrocodone. Most of the prescriptions
were issued between October and
December 2003, and were issued to
patients in California, Massachusetts,
Ohio, Oklahoma, Tennessee, Wisconsin,
Washington (State), Mississippi, South
Carolina, and Virginia.
Respondent also prescribed controlled
substances to a married couple (Mr. &
Mrs. C.W.), who had used driver’s
licenses and medical records of friends
and family members, as well as falsified
medical records (including MRIs), in
order to create multiple identities and
obtain larger quantities of drugs such as
hydrocodone and alprazolam. The
C.Ws. both consumed and sold the
drugs.
Discussion
Section 303(f) of the Controlled
Substances Act (CSA) provides that
‘‘[t]he Attorney General may deny an
application for [a practitioner’s]
registration if he determines that the
issuance of such registration would be
inconsistent with the public interest.’’
21 U.S.C. 823(f). In making the public
interest determination, the Act requires
the consideration of the following
factors:
(1) The recommendation of the appropriate
State licensing board or professional
disciplinary authority.
(2) The applicant’s experience in
dispensing * * * controlled substances.
(3) The applicant’s conviction record under
Federal or State laws relating to the
manufacture, distribution, or dispensing of
controlled substances.
(4) Compliance with applicable State,
Federal, or local laws relating to controlled
substances.
(5) Such other conduct which may threaten
the public health and safety.
Id.
[T]hese factors are * * * considered
in the disjunctive.’’ Robert A. Leslie,
M.D., 68 FR 15227, 15230 (2003). I may
rely on any one or a combination of
factors, and may give each factor the
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
6057
weight I deem appropriate in
determining whether an application for
a registration should be denied. Id.
Moreover, I am ‘‘not required to make
findings as to all of the factors.’’ Hoxie
v. DEA, 419 F.3d 477, 482 (6th Cir.
2005); see also Morall v. DEA, 412 F.3d
165, 173–74 (D.C. Cir. 2005).
Having considered all the factors, I
find that factors two and four provide
ample support for the conclusion that
granting Respondent’s application for a
registration would be ‘‘inconsistent with
the public interest.’’ 2 21 U.S.C. 823(f).
Respondent’s application will therefore
be denied.
Factor Two and Four—Respondent’s
Experience in Dispensing Controlled
Substances and Record of Compliance
With Applicable Controlled Substance
Laws
Under a longstanding DEA regulation,
a prescription for a controlled substance
is not ‘‘effective’’ unless it is ‘‘issued for
a legitimate medical purpose by an
individual practitioner acting in the
usual course of his professional
practice.’’ 21 CFR 1306.04(a). This
regulation further provides that ‘‘an
order purporting to be a prescription
issued not in the usual course of
professional treatment * * * is not a
prescription within the meaning and
intent of [21 U.S.C. 829] and * * * the
person issuing it, shall be subject to the
penalties provided for violations of the
provisions of law relating to controlled
substances.’’ Id. As the Supreme Court
recently explained, ‘‘the prescription
requirement * * * ensures patients use
controlled substances under the
supervision of a doctor so as to prevent
addiction and recreational abuse. As a
corollary, [it] also bars doctors from
peddling to patients who crave the
drugs for those prohibited uses.’’
Gonzales v. Oregon, 546 U.S. 243, 274
(2006) (citing United States v. Moore,
423 U.S. 122, 135 (1975)).
Under the CSA, it is fundamental that
a practitioner must establish a bonafide
2 I acknowledge that there is no evidence that the
State of Florida has taken any action against
Respondent’s authority under State law to prescribe
controlled substances. This Agency has long held,
however, that a State’s failure to take action against
a practitioner’s authority to dispense controlled
substances is not dispositive in determining
whether the granting of an application for
registration would be consistent with the public
interest. See Mortimer B. Levin, 55 FR 8209, 8210
(1990). I further note that Respondent alluded to his
intention to vigorously contest a pending criminal
charge based on his having engaged in the
unlicensed practice of medicine. Under agency
precedent, even if Respondent is acquitted of the
charge(s), the judgment would not be dispositive in
this proceeding, which focuses on the public
interest. Edmund Chein, 72 FR 6580, 6593 n.22
(2007).
E:\FR\FM\04FEN1.SGM
04FEN1
6058
Federal Register / Vol. 74, No. 22 / Wednesday, February 4, 2009 / Notices
doctor-patient relationship in order to
act ‘‘in the usual course of * * *
professional practice’’ and to issue a
prescription for a ‘‘legitimate medical
purpose.’’ Moore, 423 U.S. at 141–43. At
the time of the events at issue here, the
CSA generally looked to state law to
determine whether a doctor and patient
have established a bonafide doctorpatient relationship. See Kamir GarcesMejias, 72 FR 54931, 54935 (2007);
United Prescription Services, Inc., 72 FR
50397, 50407 (2007); Dispensing and
Purchasing Controlled Substances Over
the Internet, 66 FR at 21182–83.3
Moreover, shortly after the CSA’s
enactment, the Supreme Court
explained that ‘‘[i]n the case of a
physician [the Act] contemplates that he
is authorized by the State to practice
medicine and to dispense drugs in
connection with his professional
practice.’’ Moore, 423 U.S. at 140–41
(emphasis added). Accordingly, ‘‘[a]
physician who engages in the
unauthorized practice of medicine’’
under state laws ‘‘is not a ‘practitioner
acting in the usual course of * * *
professional practice’ ’’ under the CSA.
United Prescription Services, 72 FR at
50407 (quoting 21 CFR 1306.04(a)). This
rule is supported by the plain meaning
of the Act, which defines the ‘‘[t]he term
‘practitioner’ [to] mean[] a physician
* * * licensed, registered, or otherwise
permitted, by the United States or the
jurisdiction in which he practices * * *
to * * * dispense * * * a controlled
substance,’’ 21 U.S.C. 802(21), and
‘‘[t]he term ‘dispense’ [to] mean[] to
deliver a controlled substance to an
ultimate user * * * by, or pursuant to
the lawful order of, a practitioner.’’ Id.
section 802(10). See also id. section
823(f) (‘‘The Attorney General shall
register practitioners * * * to dispense
* * * if the applicant is authorized to
dispense * * * controlled substances
under the laws of the State in which he
practices.’’).
A controlled-substance prescription
issued by a physician who lacks the
3 On October 15, 2008, the President signed into
law the Ryan Haight Online Pharmacy Consumer
Protection Act of 2008, Public Law 110–425, 122
Stat. 4820 (2008). Section 2 of the Act prohibits the
dispensing of a prescription controlled substance
‘‘by means of the Internet without a valid
prescription,’’ and defines, in relevant part, ‘‘[t]he
term ‘valid prescription’ [to] mean[] a prescription
that is issued for a legitimate medical purpose in
the usual course of professional practice by * * *
a practitioner who has conducted at least 1 inperson medical evaluation of the patient.’’ 122 Stat.
4820. Section 2 further defines ‘‘[t]he term ‘inperson medical evaluation’ [to] mean[] a medical
evaluation that is conducted with the patient in the
physical presence of the practitioner, without
regard to whether portions of the evaluation are
conducted by other health professionals.’’ Id. These
provisions do not, however, apply to Respondent’s
conduct.
VerDate Nov<24>2008
14:33 Feb 03, 2009
Jkt 217001
license or other authority required to
practice medicine within a State is
therefore unlawful under the CSA. See
21 CFR 1306.04(a) (‘‘An order
purporting to be a prescription issued
not in the usual course of professional
treatment * * * is not a prescription
within the meaning an intent of’’ the
CSA); Cf. 21 CFR 1306.03(a)(1) (‘‘A
prescription for a controlled substance
may be issued only by an individual
practitioner who is * * * [a]uthorized
to prescribe controlled substances by
the jurisdiction in which he is licensed
to practice his profession[.]’’).
The investigative file establishes
numerous instances in which
Respondent violated the prescription
requirement of Federal law as well as
various state laws. As found above,
Respondent’s initial Florida medical
license expired on August 24, 2002, and
Respondent did not obtain a new
Florida license until September 16,
2005. Thus, at the time Respondent
prescribed controlled substances to
many of the customers of the Kenaday
Medical Clinic, he did not even have
authority to prescribe under Florida
law, let alone the laws of the forty other
States where his patients resided. See
Fla. Stat. §§ 456.065 (2003);
458.327(1)(a) (2003); see also, e.g., Cal.
Bus. & Prof. Code section 2052(a) (2003)
(prohibiting unlicensed practice of
medicine); Cal. Health & Safety Code
section 11352(a) (2003) (prohibiting
furnishing of a controlled substance
‘‘unless upon the written prescription of
a physician * * * licensed to practice
in this state’’); Tenn. Comp. R. & Regs.
0880–2.16 (2003) (requiring license to
‘‘engage in the practice of medicine
across state lines in this State’’).
As the California Court of Appeal has
noted, the ‘‘proscription of the
unlicensed practice of medicine is
neither an obscure nor an unusual state
prohibition of which ignorance can
reasonably be claimed, and certainly not
by persons * * * who are licensed
health care providers. Nor can such
persons reasonably claim ignorance of
the fact that authorization of a
prescription pharmaceutical constitutes
the practice of medicine.’’ Hageseth v.
Superior Court, 59 Cal. Rptr.3d 385, 403
(Ct. App. 2007). In issuing thousands of
prescriptions while lacking the
authority to do so under the laws of
both Florida and the States where the
patients resided, Respondent acted
outside of ‘‘the usual course of * * *
professional practice’’ and thereby
violated the prescription requirement of
the CSA (as well as numerous state
laws). See Moore, 423 U.S. at 140–41;
United Prescription Services, 72 FR at
50407; 21 CFR 1306.03.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Respondent violated the CSA’s
prescription requirement for an
additional reason because he did not
establish a bonafide doctor-patient
relationship with the customers of the
Web site. As Respondent admitted to
the Investigators, with the possible
exception of the small number of
customers who appeared at the clinic,
Respondent prescribed on the basis of a
telephonic consultation and did not
personally conduct a physical exam and
take a medical history from the patients.
In his interview with the
Investigators, Respondent gave two
justifications for his prescribing. First,
Respondent maintained that the law did
not provide specific guidelines that
addressed what constitutes a valid
doctor-patient relationship in the
context of the internet, asserting that
those laws were enacted when ‘‘there
was no internet,’’ and that he acted
within a loophole. Second, he
maintained that the clinic had hired
nurses or paramedics who visited the
patients and performed physical exams
on them.
As for his first contention, at the time
Respondent issued the prescriptions at
issue here, numerous States had already
adopted laws or regulations, or had
issued policy statements, which made
clear that Respondent’s internet
prescribing practices were illegal. See,
e.g., Cal. Bus. & Prof. Code section
2242.1(a); Tenn. Comp. R. & Regs. 0880–
2.14(7) (2003) (‘‘Prerequisites to Issuing
Prescriptions’’; prohibiting the
prescribing or dispensing of ‘‘any drug
to any individual, whether in person or
by electronic means or over the Internet
or over telephone lines unless the
physician, or his/her licensed
supervisee pursuant to appropriate
protocols or medical orders, has first
done and appropriately documented, for
the person to whom a prescription is to
be issued or drugs dispensed * * * an
appropriate history and physical
examination’’); Ohio Admin. Code
4731–11–09(A) (2003) (‘‘Except in
institutional settings, on call situations,
cross coverage situations, situation
involving new patients, protocol
situations involving nurses practicing in
accordance with standard care
arrangements * * * a physician shall
not prescribe, dispense, or otherwise
provide, or cause to be provided, any
controlled substance to a person who
the physician has never personally
physically examined and diagnosed.’’);
Oklahoma State Board of Medical
Licensure and Supervision, Policy on
Internet Prescribing (Ratified 01/25/01)
(‘‘Unprofessional conduct includes
‘prescribing * * * a drug * * * without
sufficient examination and the
E:\FR\FM\04FEN1.SGM
04FEN1
Federal Register / Vol. 74, No. 22 / Wednesday, February 4, 2009 / Notices
establishment of a valid physician/
patient relationship’ * * *. The
members of the Oklahoma Medical
Board have interpreted that a ‘sufficient
examination’ and ‘establishment of a
valid physician/patient relationship’
cannot take place without an initial face
to face encounter with the patient.’’)
(emphasis in original and quoting Okla.
Stat. tit. 59, section 509–13).
No more persuasive is Respondent’s
contention that his prescribings were
lawful because the clinic used nurses or
paramedics to perform physical
examinations. Respondent did not
provide any evidence to the Agency that
the clinic’s purported use of nurses to
perform physical examinations was a
lawful practice under the exceptions
recognized by any State.4
Moreover, Respondent admitted to the
Investigators that he routinely
prescribed before he obtained medical
records and in some cases he never
reviewed records. Thus, even if some
States allowed a physician to prescribe
based on an exam performed by a nurse
or paramedic in certain defined
circumstances, a physical examination
is a prerequisite to establishing a valid
doctor-patient relationship. See Tenn.
Comp R. & Regs 0880–2-.14(7).
Generally, reviewing an examination
conducted after the issuance of a
prescription is not the usual course of
professional practice.5 I thus conclude
that Respondent lacked a legitimate
medical purpose and acted outside of
the usual course of professional practice
in issuing the prescriptions.
Respondent’s prescribing practices
clearly resulted in the diversion of
controlled substances. As Respondent
acknowledged in the interview, ‘‘there
were quite a few [patients] that [were]
just doctor hopping or * * * shopping
for medication.’’ 6 Indeed, as the record
4 Even if some States authorize a physician to
prescribe in some circumstances based on a
physical exam performed by a nurse, Respondent
was required to comply with the law of every State
in which his patients resided. In any event,
Respondent did not establish that his prescribing
was lawful under the law of any State.
5 It is acknowledged that the States generally
allow a practitioner to issue a prescription in an
emergency situation before conducting a physical
exam. See 49 Pa. Code § 16.92(a). Some States also
allow a practitioner to issue a short term
continuation prescription for a new patient prior to
a patient’s first appointment, in an order admitting
a patient to a hospital, or for a patient of another
physician for whom the prescriber is taking calls.
Tenn. Comp. R. & Regs. 0880–2-.14(7)(b). None of
these exceptions apply here.
6 I reject as self-serving Respondent’s assertion
that he believed that ‘‘a good proportion of [the]
people [he prescribed to] actually needed help’’
because their original doctors had become ‘‘weary’’
of continuing to prescribe narcotics to them.
Notably, Respondent did not identify a single
instance in which he contacted the original
VerDate Nov<24>2008
14:33 Feb 03, 2009
Jkt 217001
establishes, Respondent prescribed to
two people who used falsified records
and the driver’s licenses of other
persons, to obtain such highly abused
controlled substances as hydrocodone
and alprazolam, which they both
personally abused and sold to others.
Given the thousands of prescriptions he
issued in this manner, there were likely
numerous other instances in which he
prescribed to persons who were seeking
the drugs for illicit purposes.
It is therefore clear that Respondent
committed acts which establish that
granting him a new registration would
be ‘‘inconsistent with the public
interest.’’ 21 U.S.C. 823(f).7
Respondent’s application will therefore
be denied.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f), as well as 28 CFR
0.100(b) & 0.104, I order that the
application of Ladapo O. Shyngle, M.D.,
for a DEA Certificate of Registration as
a practitioner be, and it hereby is,
denied. This order is effective March 6,
2009.
Dated: January 27, 2009.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E9–2331 Filed 2–3–09; 8:45 am]
BILLING CODE 4410–09–P
physicians of the patients to even determine
whether a patient had a legitimate medical
condition which required the continued prescribing
of a controlled substance. As Respondent himself
recognized, internet prescribing invites ‘‘doctor
hopping’’ and ‘‘medication shopping’’ by drug
abusers and drug dealers. In short, as this Agency
has found in the course of numerous investigations,
the risk of diversion inherent in internet prescribing
is extraordinary.
7 In his request for a hearing, Respondent
‘‘disagreed * * * that [the] prescriptions were
issued without a legitimate medical purpose and
outside the usual course of professional practice.’’
While Respondent’s counsel further represented
that he did not intend to ‘‘practic[e] medicine in
any way related to an Internet pharmacy,’’
Respondent has not satisfied the Agency’s standard
for obtaining a new registration, which requires that
an applicant accept responsibility for his
misconduct and acknowledge his wrongdoing. See,
e.g., Medicine Shoppe—Jonesborough, 73 FR 364,
387 (2008) (collecting cases), aff’d, Medicine
Shoppe-Jonesborough v. DEA, slip op. at 9–10 (6th
Cir. Nov. 13, 2008); Hoxie v. DEA, 419 F.3d 477,
483 (6th Cir, 2005) (‘‘admitting fault’’ is ‘‘properly
consider[ed]’’ by DEA to be an ‘‘important factor[]’’
in the public interest determination).
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
6059
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 06–72]
Foothills Family Pharmacy (Boulder)
and Foothills Family Pharmacy
(Lafayette); Declaratory Order
Terminating Registrations
On August 14, 2006, the Deputy
Assistant Administrator, Office of
Diversion Control, issued an Order to
Show Cause to Foothills Family
Pharmacy of Boulder, Colorado, and
Foothills Family Pharmacy of Lafayette,
Colorado (Respondents). The Order
proposed the revocation of each
Respondent’s DEA Certificate of
Registration as a retail pharmacy, and
the denial of any applications filed by
either Respondent to renew or modify
its registration, on the ground that each
Respondent’s ‘‘continued registration
would be inconsistent with the public
interest.’’ Show Cause Order at 1. More
specifically, the Order alleged that each
pharmacy had violated its
‘‘corresponding responsibility’’ under
Federal law by filling prescriptions for
controlled substances which were
unlawful because they were not
‘‘ ‘issued for a legitimate medical
purpose by an individual practitioner
acting in the usual course of his
professional practice.’ ’’ Id. at 3 (quoting
21 CFR 1306.04(a)).
Respondents requested a hearing on
the allegations, and the matter was
placed on the docket of the Agency’s
Administrative Law Judges (ALJ).
Following prehearing procedures, the
parties agreed to submit documents and
written statements of position to the ALJ
in lieu of a trial-type hearing.
Subsequent to their filings, the parties
also submitted briefs containing their
proposed conclusions of law and
arguments.
On June 20, 2008, the ALJ issued her
recommended decision. In her decision,
the ALJ concluded that the Government
had established that each ‘‘Respondent’s
continued registration would be
inconsistent with the public interest.’’
ALJ at 42. The ALJ thus recommended
that each Respondent’s registration be
revoked and that any pending
applications be denied. The record was
then forwarded to me for final agency
action.
Thereafter, the Government obtained
information that each Respondent was
closed and no longer conducting
business. Gov. Mot. for Declaratory
Order at 2. Accordingly, the
Government filed a motion seeking an
order declaring each Respondent’s
registration terminated on the ground
E:\FR\FM\04FEN1.SGM
04FEN1
Agencies
[Federal Register Volume 74, Number 22 (Wednesday, February 4, 2009)]
[Notices]
[Pages 6056-6059]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2331]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Ladapo O. Shyngle, M.D.; Denial of Application
On April 15, 2008, the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, issued an Order to
Show Cause to Ladapo O. Shyngle, M.D. (Respondent), of Tampa, Florida.
The Show Cause Order proposed the denial of Respondent's pending
application for a DEA Certificate of Registration as a practitioner, on
the ground that his registration ``would be inconsistent with the
public interest.'' Show Cause Order at 1.
More specifically, the Show Cause Order alleged that Respondent had
issued controlled-substance prescriptions to customers of an internet
site who were located throughout the United States based on a
questionnaire and/or telephone consultation, and that these
prescriptions lacked ``a legitimate medical purpose'' and were issued
``outside the usual course of professional practice, in violation of 21
CFR 1306.04(a) and 21 U.S.C. 841(a)(1).'' Id. The Order further alleged
that notwithstanding that his Florida medical license had expired on
August 24, 2002, Respondent continued to issue prescriptions for
controlled substances. Id. Relatedly, the Order alleged that Respondent
had violated other state laws prohibiting the unauthorized practice of
medicine by issuing prescriptions for controlled substances to
residents of States where he was not licensed to practice. Id. at 1-2.
On or about April 19, 2008, the Show Cause Order was served on
Respondent by delivery to his residence. On May 14, 2008, Respondent
requested a hearing on the allegations and the matter was placed on the
docket of the Agency's Administrative Law Judges (ALJ).
On the same date, Respondent also sought to withdraw his
application, explaining that the State of Florida had criminally
charged him with engaging in the unlicensed practice of medicine, that
he intended ``to vigorously defend'' against this charge, and that in
light of the pending proceeding, it was premature for the Agency to
consider his application. On May 29, 2008, the Deputy Assistant
Administrator denied Respondent's request, reasoning that ``the facts
supporting the Order to Show Cause will not be affected by the outcome
of the state prosecution'' and that Respondent ``intend[ed] to continue
professional medical practice and * * * reapply for a * * *
[r]egistration at the conclusion of the state criminal case.'' Letter
from Joseph T. Rannazzisi to Respondent's Counsel (May 29, 2008).
Thereafter, on July 9, 2008, Respondent withdrew his request for a
hearing. The next day, the ALJ issued an order terminating the
proceeding.
Based on Respondent's letter withdrawing his request for a hearing,
I conclude that Respondent has waived his right to a hearing. I
therefore enter this Final Order without a hearing based on relevant
material contained in the investigate file, see 21 CFR 1301.43, and
make the following findings.
Findings
On October 3, 2005, Respondent applied for a DEA Certificate of
Registration as a practitioner which would authorize him to dispense
controlled substances in schedules II through V, at the proposed
location of 1493 Tampa Park Plaza, Tampa, Florida. Respondent
previously held a practitioner's registration which was issued on
December 11, 2000, and which expired on February 29, 2004.
On August 24, 2000, the Florida Department of Health issued a
``medical doctor restricted'' license to Respondent. The license
expired, however, on August 24, 2002. Respondent did not obtain another
medical license until September 16, 2005, when the Florida Department
of Health issued him a ``medical doctor'' license. This license remains
in effect until January 31, 2010. I further find that Respondent was
not licensed in any other State when he committed the acts at issue
here.
In 2002, Respondent was hired by Kenneth Shobola, the owner of a
Tampa, Florida medical clinic (the Kenaday Medical Clinic), to perform
consultations on persons who were seeking prescriptions for controlled
substances through Shobola's Web sites. While Respondent saw some walk-
in patients at the clinic, in an interview with DEA Investigators, he
admitted that he saw only about five percent of the persons he
prescribed to, and that his contact with most of the patients was
limited to a telephone consultation which lasted five to ten minutes.
Based on the consultations, Respondent would then typically issue a
prescription for a schedule III controlled substance containing
hydrocodone; Respondent also issued prescriptions for diazepam
(Valium), a schedule IV controlled substance, 21 CFR 1308.14(c), and
some non-controlled drugs. While the prescriptions were initially
filled at F & B Pharmacy (another Tampa-based pharmacy which was
operated by Olu Oyekoya), F & B eventually pulled out of the
arrangement and all of the prescriptions were then filled by Ken Drugs,
a pharmacy owned by Shobola.
Respondent would perform up to twenty consultations a day for
Shobola's clinic. According to computer records obtained by
Investigators, Respondent issued over 3800 prescriptions which were
filled by Shobola's pharmacy. Approximately seventy-five percent of the
prescriptions were for hydrocodone, and between the original
prescriptions and refills, Respondent authorized the dispensing of more
than 500,000 dosage
[[Page 6057]]
units of the drug. Moreover, the prescriptions were issued to persons
in forty-one different States.
When asked by Investigators how he had established a doctor-patient
relationship with the patients he did not see, Respondent maintained
that he did so because he ``actually spoke to the patient on the
phone,'' and that the Web site which arranged the consultations had the
patient's medical records and ``the driver's license to identify the
patient.'' Respondent admitted, however, that because of the number of
``consults,'' ``seventy percent'' of the time he did not see a
patient's medical records until after he had issued the prescription.
Respondent also admitted that there were occasions when he never saw a
patient's medical records. Respondent even admitted that ``we did do
refills for patients'' who had not submitted records because ``the
patient [was] already in the system, [and] we already kn[ew] about this
patient.'' \1\
---------------------------------------------------------------------------
\1\ Respondent also acknowledged that a patient had to have a
physical exam at some point and maintained that the clinic had hired
either nurses or paramedics to perform physical exams on patients.
Even if true, this does not aid Respondent for two reasons: (1)
Respondent has not established the circumstances in which it may be
lawful under the laws of the various States for a physician to rely
on a physical examination performed by a nurse or paramedic, and (2)
Respondent acknowledged that seventy percent of the time he did not
see the records until after he prescribed. Respondent thus routinely
prescribed without any independent assessment and verification of
his patients' medical complaints.
---------------------------------------------------------------------------
Respondent further stated that he was ``not sure whether the law
actually gives specific guidelines as to what constitutes the patient/
physician relationship because * * * when the laws were drawn there was
no internet.'' When asked whether he was saying that he did not know if
his prescribing was legal because he did not know the law, Respondent
replied: ``No, what I'm saying is * * * I think the law the way it
stands * * * makes a loophole available in terms of * * * what
constitutes [the] patient/doctor relationship, when you * * * talk to
the patient on the phone. * * * [T]hat is a leeway that's provided and
that's what I had in mind when I got involved with * * * the whole
thing.''
Respondent acknowledged, however, that this method of prescribing
``certainly'' opened the door to drug abuse and that ``providing
medication through the internet has to provide safeguards to make sure
that the patients are genuine, [that] they're not getting multiple
drugs from different doctors and that * * * they actually have the
problem that they're taking about.'' Moreover, Respondent stated to
Investigators that ``the way we practiced * * * in Kennedy there's no
way you could get all of those [illegitimate patients] out of the
system * * * 100% of the time.'' Respondent further asserted that
``there was a good proportion of people that actually needed help that
got the help,'' but acknowledged that ``there were quite a few that
[were] just doctor hopping or * * * shopping for medication.''
As examples of Respondent's prescribing, the Government submitted
copies of fourteen prescriptions which Respondent issued for such drugs
as Norco (10/325 mg.), Lortab (10/500 mg.), Vicoprofen (7.5/200 mg.),
and Vicodin (7.5/750 mg.), all of which are schedule III controlled
substances containing hydrocodone. Most of the prescriptions were
issued between October and December 2003, and were issued to patients
in California, Massachusetts, Ohio, Oklahoma, Tennessee, Wisconsin,
Washington (State), Mississippi, South Carolina, and Virginia.
Respondent also prescribed controlled substances to a married
couple (Mr. & Mrs. C.W.), who had used driver's licenses and medical
records of friends and family members, as well as falsified medical
records (including MRIs), in order to create multiple identities and
obtain larger quantities of drugs such as hydrocodone and alprazolam.
The C.Ws. both consumed and sold the drugs.
Discussion
Section 303(f) of the Controlled Substances Act (CSA) provides that
``[t]he Attorney General may deny an application for [a practitioner's]
registration if he determines that the issuance of such registration
would be inconsistent with the public interest.'' 21 U.S.C. 823(f). In
making the public interest determination, the Act requires the
consideration of the following factors:
(1) The recommendation of the appropriate State licensing board
or professional disciplinary authority.
(2) The applicant's experience in dispensing * * * controlled
substances.
(3) The applicant's conviction record under Federal or State
laws relating to the manufacture, distribution, or dispensing of
controlled substances.
(4) Compliance with applicable State, Federal, or local laws
relating to controlled substances.
(5) Such other conduct which may threaten the public health and
safety.
Id.
[T]hese factors are * * * considered in the disjunctive.'' Robert
A. Leslie, M.D., 68 FR 15227, 15230 (2003). I may rely on any one or a
combination of factors, and may give each factor the weight I deem
appropriate in determining whether an application for a registration
should be denied. Id. Moreover, I am ``not required to make findings as
to all of the factors.'' Hoxie v. DEA, 419 F.3d 477, 482 (6th Cir.
2005); see also Morall v. DEA, 412 F.3d 165, 173-74 (D.C. Cir. 2005).
Having considered all the factors, I find that factors two and four
provide ample support for the conclusion that granting Respondent's
application for a registration would be ``inconsistent with the public
interest.'' \2\ 21 U.S.C. 823(f). Respondent's application will
therefore be denied.
---------------------------------------------------------------------------
\2\ I acknowledge that there is no evidence that the State of
Florida has taken any action against Respondent's authority under
State law to prescribe controlled substances. This Agency has long
held, however, that a State's failure to take action against a
practitioner's authority to dispense controlled substances is not
dispositive in determining whether the granting of an application
for registration would be consistent with the public interest. See
Mortimer B. Levin, 55 FR 8209, 8210 (1990). I further note that
Respondent alluded to his intention to vigorously contest a pending
criminal charge based on his having engaged in the unlicensed
practice of medicine. Under agency precedent, even if Respondent is
acquitted of the charge(s), the judgment would not be dispositive in
this proceeding, which focuses on the public interest. Edmund Chein,
72 FR 6580, 6593 n.22 (2007).
---------------------------------------------------------------------------
Factor Two and Four--Respondent's Experience in Dispensing Controlled
Substances and Record of Compliance With Applicable Controlled
Substance Laws
Under a longstanding DEA regulation, a prescription for a
controlled substance is not ``effective'' unless it is ``issued for a
legitimate medical purpose by an individual practitioner acting in the
usual course of his professional practice.'' 21 CFR 1306.04(a). This
regulation further provides that ``an order purporting to be a
prescription issued not in the usual course of professional treatment *
* * is not a prescription within the meaning and intent of [21 U.S.C.
829] and * * * the person issuing it, shall be subject to the penalties
provided for violations of the provisions of law relating to controlled
substances.'' Id. As the Supreme Court recently explained, ``the
prescription requirement * * * ensures patients use controlled
substances under the supervision of a doctor so as to prevent addiction
and recreational abuse. As a corollary, [it] also bars doctors from
peddling to patients who crave the drugs for those prohibited uses.''
Gonzales v. Oregon, 546 U.S. 243, 274 (2006) (citing United States v.
Moore, 423 U.S. 122, 135 (1975)).
Under the CSA, it is fundamental that a practitioner must establish
a bonafide
[[Page 6058]]
doctor-patient relationship in order to act ``in the usual course of *
* * professional practice'' and to issue a prescription for a
``legitimate medical purpose.'' Moore, 423 U.S. at 141-43. At the time
of the events at issue here, the CSA generally looked to state law to
determine whether a doctor and patient have established a bonafide
doctor-patient relationship. See Kamir Garces-Mejias, 72 FR 54931,
54935 (2007); United Prescription Services, Inc., 72 FR 50397, 50407
(2007); Dispensing and Purchasing Controlled Substances Over the
Internet, 66 FR at 21182-83.\3\
---------------------------------------------------------------------------
\3\ On October 15, 2008, the President signed into law the Ryan
Haight Online Pharmacy Consumer Protection Act of 2008, Public Law
110-425, 122 Stat. 4820 (2008). Section 2 of the Act prohibits the
dispensing of a prescription controlled substance ``by means of the
Internet without a valid prescription,'' and defines, in relevant
part, ``[t]he term `valid prescription' [to] mean[] a prescription
that is issued for a legitimate medical purpose in the usual course
of professional practice by * * * a practitioner who has conducted
at least 1 in-person medical evaluation of the patient.'' 122 Stat.
4820. Section 2 further defines ``[t]he term `in-person medical
evaluation' [to] mean[] a medical evaluation that is conducted with
the patient in the physical presence of the practitioner, without
regard to whether portions of the evaluation are conducted by other
health professionals.'' Id. These provisions do not, however, apply
to Respondent's conduct.
---------------------------------------------------------------------------
Moreover, shortly after the CSA's enactment, the Supreme Court
explained that ``[i]n the case of a physician [the Act] contemplates
that he is authorized by the State to practice medicine and to dispense
drugs in connection with his professional practice.'' Moore, 423 U.S.
at 140-41 (emphasis added). Accordingly, ``[a] physician who engages in
the unauthorized practice of medicine'' under state laws ``is not a
`practitioner acting in the usual course of * * * professional
practice' '' under the CSA. United Prescription Services, 72 FR at
50407 (quoting 21 CFR 1306.04(a)). This rule is supported by the plain
meaning of the Act, which defines the ``[t]he term `practitioner' [to]
mean[] a physician * * * licensed, registered, or otherwise permitted,
by the United States or the jurisdiction in which he practices * * * to
* * * dispense * * * a controlled substance,'' 21 U.S.C. 802(21), and
``[t]he term `dispense' [to] mean[] to deliver a controlled substance
to an ultimate user * * * by, or pursuant to the lawful order of, a
practitioner.'' Id. section 802(10). See also id. section 823(f) (``The
Attorney General shall register practitioners * * * to dispense * * *
if the applicant is authorized to dispense * * * controlled substances
under the laws of the State in which he practices.'').
A controlled-substance prescription issued by a physician who lacks
the license or other authority required to practice medicine within a
State is therefore unlawful under the CSA. See 21 CFR 1306.04(a) (``An
order purporting to be a prescription issued not in the usual course of
professional treatment * * * is not a prescription within the meaning
an intent of'' the CSA); Cf. 21 CFR 1306.03(a)(1) (``A prescription for
a controlled substance may be issued only by an individual practitioner
who is * * * [a]uthorized to prescribe controlled substances by the
jurisdiction in which he is licensed to practice his profession[.]'').
The investigative file establishes numerous instances in which
Respondent violated the prescription requirement of Federal law as well
as various state laws. As found above, Respondent's initial Florida
medical license expired on August 24, 2002, and Respondent did not
obtain a new Florida license until September 16, 2005. Thus, at the
time Respondent prescribed controlled substances to many of the
customers of the Kenaday Medical Clinic, he did not even have authority
to prescribe under Florida law, let alone the laws of the forty other
States where his patients resided. See Fla. Stat. Sec. Sec. 456.065
(2003); 458.327(1)(a) (2003); see also, e.g., Cal. Bus. & Prof. Code
section 2052(a) (2003) (prohibiting unlicensed practice of medicine);
Cal. Health & Safety Code section 11352(a) (2003) (prohibiting
furnishing of a controlled substance ``unless upon the written
prescription of a physician * * * licensed to practice in this
state''); Tenn. Comp. R. & Regs. 0880-2.16 (2003) (requiring license to
``engage in the practice of medicine across state lines in this
State'').
As the California Court of Appeal has noted, the ``proscription of
the unlicensed practice of medicine is neither an obscure nor an
unusual state prohibition of which ignorance can reasonably be claimed,
and certainly not by persons * * * who are licensed health care
providers. Nor can such persons reasonably claim ignorance of the fact
that authorization of a prescription pharmaceutical constitutes the
practice of medicine.'' Hageseth v. Superior Court, 59 Cal. Rptr.3d
385, 403 (Ct. App. 2007). In issuing thousands of prescriptions while
lacking the authority to do so under the laws of both Florida and the
States where the patients resided, Respondent acted outside of ``the
usual course of * * * professional practice'' and thereby violated the
prescription requirement of the CSA (as well as numerous state laws).
See Moore, 423 U.S. at 140-41; United Prescription Services, 72 FR at
50407; 21 CFR 1306.03.
Respondent violated the CSA's prescription requirement for an
additional reason because he did not establish a bonafide doctor-
patient relationship with the customers of the Web site. As Respondent
admitted to the Investigators, with the possible exception of the small
number of customers who appeared at the clinic, Respondent prescribed
on the basis of a telephonic consultation and did not personally
conduct a physical exam and take a medical history from the patients.
In his interview with the Investigators, Respondent gave two
justifications for his prescribing. First, Respondent maintained that
the law did not provide specific guidelines that addressed what
constitutes a valid doctor-patient relationship in the context of the
internet, asserting that those laws were enacted when ``there was no
internet,'' and that he acted within a loophole. Second, he maintained
that the clinic had hired nurses or paramedics who visited the patients
and performed physical exams on them.
As for his first contention, at the time Respondent issued the
prescriptions at issue here, numerous States had already adopted laws
or regulations, or had issued policy statements, which made clear that
Respondent's internet prescribing practices were illegal. See, e.g.,
Cal. Bus. & Prof. Code section 2242.1(a); Tenn. Comp. R. & Regs. 0880-
2.14(7) (2003) (``Prerequisites to Issuing Prescriptions''; prohibiting
the prescribing or dispensing of ``any drug to any individual, whether
in person or by electronic means or over the Internet or over telephone
lines unless the physician, or his/her licensed supervisee pursuant to
appropriate protocols or medical orders, has first done and
appropriately documented, for the person to whom a prescription is to
be issued or drugs dispensed * * * an appropriate history and physical
examination''); Ohio Admin. Code 4731-11-09(A) (2003) (``Except in
institutional settings, on call situations, cross coverage situations,
situation involving new patients, protocol situations involving nurses
practicing in accordance with standard care arrangements * * * a
physician shall not prescribe, dispense, or otherwise provide, or cause
to be provided, any controlled substance to a person who the physician
has never personally physically examined and diagnosed.''); Oklahoma
State Board of Medical Licensure and Supervision, Policy on Internet
Prescribing (Ratified 01/25/01) (``Unprofessional conduct includes
`prescribing * * * a drug * * * without sufficient examination and the
[[Page 6059]]
establishment of a valid physician/patient relationship' * * *. The
members of the Oklahoma Medical Board have interpreted that a
`sufficient examination' and `establishment of a valid physician/
patient relationship' cannot take place without an initial face to face
encounter with the patient.'') (emphasis in original and quoting Okla.
Stat. tit. 59, section 509-13).
No more persuasive is Respondent's contention that his prescribings
were lawful because the clinic used nurses or paramedics to perform
physical examinations. Respondent did not provide any evidence to the
Agency that the clinic's purported use of nurses to perform physical
examinations was a lawful practice under the exceptions recognized by
any State.\4\
---------------------------------------------------------------------------
\4\ Even if some States authorize a physician to prescribe in
some circumstances based on a physical exam performed by a nurse,
Respondent was required to comply with the law of every State in
which his patients resided. In any event, Respondent did not
establish that his prescribing was lawful under the law of any
State.
---------------------------------------------------------------------------
Moreover, Respondent admitted to the Investigators that he
routinely prescribed before he obtained medical records and in some
cases he never reviewed records. Thus, even if some States allowed a
physician to prescribe based on an exam performed by a nurse or
paramedic in certain defined circumstances, a physical examination is a
prerequisite to establishing a valid doctor-patient relationship. See
Tenn. Comp R. & Regs 0880-2-.14(7). Generally, reviewing an examination
conducted after the issuance of a prescription is not the usual course
of professional practice.\5\ I thus conclude that Respondent lacked a
legitimate medical purpose and acted outside of the usual course of
professional practice in issuing the prescriptions.
---------------------------------------------------------------------------
\5\ It is acknowledged that the States generally allow a
practitioner to issue a prescription in an emergency situation
before conducting a physical exam. See 49 Pa. Code Sec. 16.92(a).
Some States also allow a practitioner to issue a short term
continuation prescription for a new patient prior to a patient's
first appointment, in an order admitting a patient to a hospital, or
for a patient of another physician for whom the prescriber is taking
calls. Tenn. Comp. R. & Regs. 0880-2-.14(7)(b). None of these
exceptions apply here.
---------------------------------------------------------------------------
Respondent's prescribing practices clearly resulted in the
diversion of controlled substances. As Respondent acknowledged in the
interview, ``there were quite a few [patients] that [were] just doctor
hopping or * * * shopping for medication.'' \6\ Indeed, as the record
establishes, Respondent prescribed to two people who used falsified
records and the driver's licenses of other persons, to obtain such
highly abused controlled substances as hydrocodone and alprazolam,
which they both personally abused and sold to others. Given the
thousands of prescriptions he issued in this manner, there were likely
numerous other instances in which he prescribed to persons who were
seeking the drugs for illicit purposes.
---------------------------------------------------------------------------
\6\ I reject as self-serving Respondent's assertion that he
believed that ``a good proportion of [the] people [he prescribed to]
actually needed help'' because their original doctors had become
``weary'' of continuing to prescribe narcotics to them. Notably,
Respondent did not identify a single instance in which he contacted
the original physicians of the patients to even determine whether a
patient had a legitimate medical condition which required the
continued prescribing of a controlled substance. As Respondent
himself recognized, internet prescribing invites ``doctor hopping''
and ``medication shopping'' by drug abusers and drug dealers. In
short, as this Agency has found in the course of numerous
investigations, the risk of diversion inherent in internet
prescribing is extraordinary.
---------------------------------------------------------------------------
It is therefore clear that Respondent committed acts which
establish that granting him a new registration would be ``inconsistent
with the public interest.'' 21 U.S.C. 823(f).\7\ Respondent's
application will therefore be denied.
---------------------------------------------------------------------------
\7\ In his request for a hearing, Respondent ``disagreed * * *
that [the] prescriptions were issued without a legitimate medical
purpose and outside the usual course of professional practice.''
While Respondent's counsel further represented that he did not
intend to ``practic[e] medicine in any way related to an Internet
pharmacy,'' Respondent has not satisfied the Agency's standard for
obtaining a new registration, which requires that an applicant
accept responsibility for his misconduct and acknowledge his
wrongdoing. See, e.g., Medicine Shoppe--Jonesborough, 73 FR 364, 387
(2008) (collecting cases), aff'd, Medicine Shoppe-Jonesborough v.
DEA, slip op. at 9-10 (6th Cir. Nov. 13, 2008); Hoxie v. DEA, 419
F.3d 477, 483 (6th Cir, 2005) (``admitting fault'' is ``properly
consider[ed]'' by DEA to be an ``important factor[]'' in the public
interest determination).
---------------------------------------------------------------------------
Order
Pursuant to the authority vested in me by 21 U.S.C. 823(f), as well
as 28 CFR 0.100(b) & 0.104, I order that the application of Ladapo O.
Shyngle, M.D., for a DEA Certificate of Registration as a practitioner
be, and it hereby is, denied. This order is effective March 6, 2009.
Dated: January 27, 2009.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E9-2331 Filed 2-3-09; 8:45 am]
BILLING CODE 4410-09-P